← Back to Patent Explorer
US4368197A Expired / Lapsed US ⏱️ 0.0 years remaining

Zinc aminophylline and its use in the treatment of bronchospasms

Assignee: Research Corp
•
Filing: 1980-11-07
•
Granted: 1983-01-11
•
Expires: 2000-11-07
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract There is disclosed zinc complexes of amine salts of theophylline. The preferred compound disclosed is the zinc complex of aminophylline. These compounds are useful as bronchodilators and have antibronchospasmotic activity. They are substantially insoluble and do not impart an unpleasant taste to oral formulations. In addition, they are storage stable. The compounds are prepared by reacting a water soluble simple zinc salt with the amine salt of theophylline at temperatures of from 60°-90° C. for about 8 to 16 hours.

Inventors

  • 👤 Eli Shefter
  • 👤 Francis X. Smith
  • 👤 Mark J. Gardner

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-01 04:03
CPC Classifications
C; C07; C07D; C07D473/00; C07D473/02; C07D473/04; C07D473/06; C07D473/08

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 34 words
A compound represented by the formula ##STR2## wherein R and R' are each a primary monoamine or ammonia or taken together are a lower alkyl primary diamine having from 2 to 6 carbon atoms.
Claim 2
Dependent Claim 34 words
A compound represented by the formula ##STR2## wherein R and R' are each a primary monoamine or ammonia or taken together are a lower alkyl primary diamine having from 2 to 6 carbon atoms.
Claim 3
Dependent Claim 12 words
The compound of claim 1, which is the zinc complex of aminophylline.
Claim 4
Dependent Claim 27 words
A chewable tablet containing an amount of the zinc complex of aminophylline which can be used to effectively treat bronchospasms and pharmaceutically acceptable tabletting adjuvants and excipients.
Claim 5
Dependent Claim 27 words
A chewable tablet containing an amount of the zinc complex of aminophylline which can be used to effectively treat bronchospasms and pharmaceutically acceptable tabletting adjuvants and excipients.
Claim 6
Dependent Claim 32 words
A pharmaceutical suspension suitable for oral administration containing an amount of the zinc complex of aminophylline which can be used to effectively treat bronchospasms and pharmaceutically acceptable oral suspension adjuvants and excipients.
Claim 7
Dependent Claim 32 words
A pharmaceutical suspension suitable for oral administration containing an amount of the zinc complex of aminophylline which can be used to effectively treat bronchospasms and pharmaceutically acceptable oral suspension adjuvants and excipients.
Claim 8
Dependent Claim 26 words
A method of treating an asthmatic patient to relieve bronchospasms which comprises orally administering to said patient an effective amount of the composition of claim 3.
Claim 9
Dependent Claim 25 words
A method of treating asthmatic patients to relieve bronchospasms which comprises orally administering to said patient an effective amount of the composition of claim 4.

References Cited (Backward Citations)

US2008252A Cited
US2667439A Cited
US3856805A Cited
US3830825A Cited
US3830824A Cited
US3830908A Cited
US4049802A Cited
US4031218A Cited
US4085214A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1986-01-10 1986-07-12 1987-01-11 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1990-01-10 1990-07-12 1991-01-11 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1994-01-10 1994-07-12 1995-01-11 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag